Philip Daffas

Philip Daffas

Directeur Général chez PAINCHEK LIMITED

Fortune : 313 696 $ au 31/05/2026

Health Technology
Consumer Services
Commercial Services

Profil

Philip Daffas is currently Managing Director & Non-Executive Director at PainChek Ltd. since 2016.
Former positions include Chief Executive Officer at Applied Physiology Pty Ltd., Global Marketing Director at Roche Diagnostics GmbH, Managing Director at Bio-Rad Laboratories Pty Ltd., Vice President-Global Marketing at Cochlear Ltd. from 1997 to 2002, Head-Sales & Marketing at IVAC Corp., Principal at Shiley Infusaid, Inc., and General Manager at Roche Diagnostics Australia Pty Ltd. Education includes an MBA from Kingston University and undergraduate studies at the University of Westminster.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
06/07/2026 3 114 226 ( 1,49 % ) 313 696 $ 31/05/2026

Postes actifs de Philip Daffas

SociétésPosteDébut
PAINCHEK LIMITED Directeur Général 30/09/2016

Anciens postes connus de Philip Daffas

SociétésPosteFin
COCHLEAR LIMITED Sales & Marketing 01/01/2002
Bio-Rad Laboratories Pty Ltd.
Corporate Officer/Principal -
Roche Diagnostics Australia Pty Ltd.
Corporate Officer/Principal -
Sales & Marketing -
Shiley Infusaid, Inc.
Corporate Officer/Principal -
Voir l'expérience en détail de Philip Daffas

Formation de Philip Daffas

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

13

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Distribution Services

Shiley Infusaid, Inc.

Bio-Rad Laboratories Pty Ltd.

Technology Services

Roche Diagnostics Australia Pty Ltd.

  1. Bourse
  2. Insiders
  3. Philip Daffas
🔇